![](/img/cover-not-exists.png)
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery: Prospective randomized double-masked clinical trial
Hon-Vu Q. Duong, Kenneth C. Westfield, Thomas H.F. ChalkleyVolume:
33
Year:
2007
Language:
english
DOI:
10.1016/j.jcrs.2007.07.017
File:
PDF, 189 KB
english, 2007